Yuan‐Pin Hung

Lauric Acid Is an Inhibitor of Clostridium difficile Growth in Vitro and Reduces Inflammation in a Mouse Infection Model

Hsiao-Ting Yang, Jenn‐Wei Chen, Jagat Rathod et al. · Frontiers in Microbiology · 2018 · 114 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?

Yuan‐Pin Hung, Jen‐Chieh Lee, Chun-Wei Chiu et al. · Antibiotics · 2022 · 94 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Cheng‐Pin Chen, Yi‐Chun Lin, Tsung‐Chia Chen et al. · PLoS ONE · 2020 · 81 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Cytomegalovirus disease in nonimmunocompromised, human immunodeficiency virus-negative adults with chronic kidney disease

Yao-Ming Chen, Yuan‐Pin Hung, Chien-Fang Huang et al. · Journal of Microbiology Immunology and Infection · 2013 · 55 citations

Life Sciences, Infectious Diseases, Internal Medicine +14

Impact of Toxigenic Clostridium difficile Colonization and Infection among Hospitalized Adults at a District Hospital in Southern Taiwan

Yuan‐Pin Hung, Pei-Jane Tsai, Kuei‐Hsiang Hung et al. · PLoS ONE · 2012 · 53 citations · Full text

Veterinary Medicine, Infectious Diseases, Diagnostic Microbiology +13